Adrenergic Bronchodilators, Old and New

References

• Chen K K, Schmidt C F. The action of ephedrine, the active principal of the Chinese drug Ma Huang. J Pharmacol Exp Therap 1924; 24: 192
   Google Scholar
• May C D. History of the introduction of the-ophylline into the treatment of asthma. Clin Allergy 1974; 4: 211
   PubMedGoogle Scholar
• Weinberger M M, Bronsky E. Evaluation of oral bronchodilator therapy in asthmatic children. J Pediatr 1974; 84: 421
   PubMed Web of Science ®Google Scholar
• Ahlquist R P. A study of adrenotropic receptors. Am J Physiol 1948; 153: 586
   PubMed Web of Science ®Google Scholar
• Lands A M, Arnold A, McAuliff J P, Luduena F P, Brown T G. Differentiation of receptor systems activated by sympathomimetic amines. Nature London 1967; 214: 597
   PubMed Web of Science ®Google Scholar
• Tattersfield A E, McNicol M W. Salbutamol and isoproterenol: a double blind trial to compare bronchodilator and cardiovascular activity. N Engl J Med 1969; 281: 1328
   Google Scholar
• Snider G L, Laguarda R. Albuterol and isoproterenol aerosols: a controlled study of the duration of effect in asthmatic patients. J Am Med Assoc 1972; 1: 682
   Google Scholar
• Cotton E K, Parry W. Treatment of status asth-maticus and respiratory failure. Pediatr Clin N Am 1975; 22: 163
   PubMed Web of Science ®Google Scholar
• Wood D W, Downes J J, Scheinkopf H, Leeks H I. Intravenous isoproterenol in the management of respiratory failure in childhood status asth-maticus. J Allergy Clin Immunol 1972; 50: 75
   PubMed Web of Science ®Google Scholar
• Sinha B N, Allan G W, Lees A W. Oral or-ciprenaline, salbutamol, and isoetharine compared. Br J Dis Chest 1973; 67: 61
   PubMedGoogle Scholar
• Redwood D. Intravenous isoprenaline and or-ciprenaline as a guide to the drug therapy of Stoke-Adams attacks. Br Med J 1968; 1: 419
   PubMedGoogle Scholar
• Freedman B J. Trial of a terbutaline aerosol in the treatment of asthma and comparison of its effect with those of salbutamol aerosol. Br J Dis Chest 1972; 66: 222
   PubMedGoogle Scholar
• Gaddie J, Legge J S, Palmer K NV. Aerosols of salbutamol, terbutaline, and isoprenaline/phenyl-ephrine in asthma. Br J Dis Chest 1972; 66: 222
   PubMedGoogle Scholar
• Spector S L, Gomez M G. Dose response effects of albuterol aerosol compared with isoproterenol and placebo aerosols. J Allergy Clin Immunol 1977; 59: 280
   PubMedGoogle Scholar
• McLeod J, Selman J. A comparison of Berotec (Th1165a) and salbutamol aerosols. New Zealand Med J 1973; 78: 209
   PubMedGoogle Scholar
• Chervinsky P. Six-week double blind trial of oral fenoterol and terbutaline. Am Rev Resp Dis 1977; 115: 50
   Google Scholar
• Krieger E. Bronchial antispasmodic effect in obstructive respiratory disorders. Double blind comparison of Aludrin, Alupent and Berotec and placebo. Int J Clin Pharmacol, Therapy Toxicol 1971; 4(Suppl)102
   Google Scholar
• Beardshaw J, McLean L, Chan-Yeung M. Comparison of the bronchodilator and cardiac effects of hydroxyphenylorciprenaline and orciprenaline. Chest 1974; 65: 507
   PubMed Web of Science ®Google Scholar
• Geumei A M, Miller W F, Miller J, Gast L R. Bronchodilator effect of a new oral beta adenoreceptor stimulant (Th1165a), a comparison with meta-proterenol sulfate. Chest 1976; 70: 460
   PubMedGoogle Scholar
• Zanetti C L, Rotman H H, Dresner A J. Efficacy and duration of action of procaterol, a new bronchodilator. J Clin Pharmacol 1982; 22: 250
   PubMedGoogle Scholar
• Littner M R, Tashkin D P, Calvarese B, Bautista M. Acute bronchial and cardiovascular effects of increasing doses of pirbuterol acetate aerosol in asthma. Ann Allergy 1982; 48: 14
   PubMedGoogle Scholar
• Kass I, Mingo T S. Bitolterol mesylate (WIN 32784) aerosol, a new long-acting broncholdilator with reduced chronotropic effects. Chest 1980; 78: 283
   PubMedGoogle Scholar
• Kemp J P, Meltzer E O, Orgel H A, Mingo T S. Prolonged bronchodilation without cardiac effects using bitolterol mesylate aerosol (new beta agonist) and oral theophylline in asthma. In XI International Congress of Allergology and Immunology. 1982, Abstract 682
   Google Scholar
• Kuhn G J, Weliky I, Santiago S M, Klaustermeyer W B. Inhibition of antigen-induced bron-choconstriction with reproterol, a new beta agonist—Xanthine derivative. Ann Allergy 1981; 46: 193
   PubMedGoogle Scholar
• Larsson S, Svedmyr N. Tremor caused by sym-pathomimetics is mediated by beta2 adenorecep-tors. Scand J Resp Dis 1977; 58: 5
   PubMedGoogle Scholar
• Minette A. Ventilatory results and side effects of salbutamol given by different routes in coal miners with reversible broncho-obstruction. Postgrad Med J 1971; 4(Suppl)55
   Google Scholar
• Larsson S, Svedmyr N. Bronchodilating effect and side effects of beta2 adenoreceptor stimulants by different modes of administration (tablets, me-tered aerosol and combinations thereof); a study with salbutamol in asthmatics. Am Rev Resp Dis 1977; 116: 861
   PubMed Web of Science ®Google Scholar
• Paterson I C, Crompton G K. Use of pressurized aerosol by asthmatic patients. Br Med J 1976; 1: 76
   PubMed Web of Science ®Google Scholar
• Ruffin R E, Montgomery J M, Newhouse M T. Site of beta adrenergic receptors in the respiratory tract. Chest 1978; 74: 256
   PubMed Web of Science ®Google Scholar
• Pavia D, Thompson M L, Clarke S W, et al. Effect of lung function and mode of inhalation on penetration of aerosol into human lung. Thorax 1977; 32: 194
   PubMed Web of Science ®Google Scholar
• Palmes E D. Measurement of pulmonary air spaces using aerosols. Arch Intern Med 1973; 131: 76
   PubMed Web of Science ®Google Scholar
• Dolovich M D, Ruffin R E, Roberts R, et al. Optimal delivery of aerosols from meter-dose inhalers. Chest 1981; 80(Suppl)911
   PubMedGoogle Scholar
• Newman S P, Pavia D, Moren F, et al. Deposition of pressurized aerosols in the human respiratory tract. Thorax 1981; 36: 52
   PubMed Web of Science ®Google Scholar
• Newman S P, Moren F, Pavia D, et al. Deposition of pressurized aerosols inhaled through extension devices. Am Rev Resp Dis 1981; 124: 317
   PubMed Web of Science ®Google Scholar
• Hetzel M R, Clark T JH. Comparison of salbutamol rotahaler with conventional pressurized aerosol. Clin Allergy 1977; 7: 653
   Google Scholar
• Bundgaad A, Schmidt A. Pre-treatment of exercise-induced asthma by fenoterol delivered as inhalation powder and pressurized aerosol. Ann Allergy 1982; 48: 36
   PubMedGoogle Scholar
• Wilson J D, Sutherland D C, Thomas A C. Has the change to beta agonist combined with oral theophylline increased cases of fatal asthma?. Lancet 1981; 2: 1235
   Google Scholar
• Joseph X, Whitehurst V E, Bloom S, Balazs T. Enhancement of cardiotoxic effects of beta adrenergic bronchodilators by aminophylline in experimental animals. Fund Appl Toxicol 1981; 1: 443
   PubMedGoogle Scholar
• Interactions between methylxanthines and beta adrenergic agents. FDA Drug Bull November, 1981; 11(3)19
   PubMedGoogle Scholar
• Chervinsky P, Noyes J H, Mingo T S. Evaluation of therapy with aerosolized bitolterol mesylate and oral theophylline given alone and concomitantly to patients with asthma. J Allergy Clin Immunol 1982; 69(No 1)153, Abstract No 244 Part 2
   Google Scholar
• Patel A K, Skatrud J B, Thomsen J H. Cardiac arrhythmia due to oral theophylline in patients with chronic obstructive pulmonary disease. Chest 1981; 80: 661
   PubMedGoogle Scholar
• Svedmyr N C, Larsson S A, Theringer G K. Development of “resistance” in beta adrenergic receptors of asthmatic patients. Chest 1967; 69: 479
   Google Scholar
• Nelson H S, Raine D, Jr, Posey W C. Subsensitivity to the bronchodilator action of albuterol produced by chronic administration. Am Rev Resp Dis 1977; 166: 871
   Google Scholar
• Larsson S A, Svedmyr N C, Theringer G K. Lack of bronchial beta adenoreceptor resistance in asthmatics during long-term treatment with ter-butaline. J Allergy Clin Immunol 1976; 59: 93
   Google Scholar
• Jenne J W, Chick T W, Strickland R W, Wall F J. Subsensitivity of beta responses during therapy with a long-acting beta2 preparation. J Allergy Clin Immunol 1977; 59: 383
   PubMedGoogle Scholar
• McFadden E R, Jr. Beta2 receptor agonists: Metabolism and pharmacology. J Allergy Clin Immunol 1981; 68: 91
   PubMed Web of Science ®Google Scholar
• Nelson H S. Beta adrenergic agonists. Chest July, 1982; 33S, (Suppl)
   Google Scholar
• Holgate S T, Baldwin C J, Pattersfield A E. Beta adrenergic agonist resistance in normal human airways. Lancet 1977; 2: 375
   PubMed Web of Science ®Google Scholar
• Ellul-Micallef R, French F F. Effective intravenous prednisolone in asthmatics with diminished adrenergic responsiveness. Lancet 1975; 2: 1269
   PubMed Web of Science ®Google Scholar
• Jenne J W. Whither beta adrenergic tachyphylaxis?. J Allergy Clin Immunol 1982; 70: 413
   PubMedGoogle Scholar